Daunorubicin Hydrochloride (CAS 23541-50-6) Supplier Information

Daunorubicin hydrochloride is categorized under Antitumour agents, Carbohydrates Derivatives, Intermediates, Fine Chemicals, Pharmaceuticals, Chiral Reagents, Heterocycles, API, Anti-cancer immunity, and Coronavirus-related compounds.

Synonyms include: - 5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (1S,3S)- - Daunoblastin - Daunoblastina - Daunomycin chlorohydrate - NDC0082-4155 - Ondena - RP-13057 hydrochloride - Rubidomycin hydrochloride

Frequently Asked Questions about Daunorubicin Hydrochloride

Q: What is Daunorubicin Hydrochloride used for?

A: Daunorubicin Hydrochloride is primarily used as an antitumor agent in cancer treatment, particularly for acute myeloid leukemia and acute lymphocytic leukemia.

Q: How is Daunorubicin Hydrochloride stored?

A: Daunorubicin Hydrochloride should be stored under inert conditions to maintain its stability. Specific storage requirements may vary, so it's best to consult the manufacturer's guidelines.

Q: What is the purity of commercially available Daunorubicin Hydrochloride?

A: Based on the supplier information, Daunorubicin Hydrochloride is typically available with a purity of 98-99%.

Q: Is Daunorubicin Hydrochloride available for research purposes?

A: Yes, Daunorubicin Hydrochloride is available from various suppliers in different package sizes, suitable for research and development purposes in pharmaceutical and academic settings.